Extrahepatic Drug‐Metabolizing Enzymes and Their Significance
- 15 October 2012
- book chapter
- Published by Wiley
- p. 1-99
Abstract
Drug‐metabolizing enzymes (DMEs) are primarily expressed in the liver but their role in the extrahepatic tissues such as gastrointestinal tract (GIT), pulmonary, excretory, nervous, cardiovascular system, and skin cannot be neglected. Generally, the expression of DMEs in extrahepatic tissues is quantitatively lower than that in the liver, but there are a few enzymes such as CYP1A1, CYP1B1, CYP2F1, and CYP2U1 that are more abundant in extrahepatic organs. As many extrahepatic organs are portals for administered drugs, DMEs expressed in these organs can be responsible for significant metabolism, leading to first‐pass effects and lower bioavailability. Extrahepatic DMEs are also involved in bioactivation of prodrugs and formation of reactive metabolites that may interact with cellular components, resulting in organ‐specific toxicity. Activity and expression of extrahepatic DMEs is often altered by coadministered drugs, leading to drug–drug interactions. Expression of DMEs in living beings affected by a host of environmental and genetic factors such as genetic polymorphism, age, gender, pathophysiological conditions, inborn errors in metabolism, food habits, and environmental pollutants, contributing to varied drug effects and idiosyncratic toxicities.Keywords
This publication has 588 references indexed in Scilit:
- Influence of the COMT Genotype on Working Memory and Brain Activity Changes During DevelopmentBiological Psychiatry, 2011
- Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicityPediatric Nephrology, 2005
- Expression Profiling of Human Sulfotransferase and Sulfatase Gene Superfamilies in Epithelial Tissues and Cultured CellsBiochemical and Biophysical Research Communications, 2000
- Expression and Localization of Human Alcohol and Aldehyde Dehydrogenase Enzymes in SkinBiochemical and Biophysical Research Communications, 1999
- Evidence for a Tissue-Specific Induction of Cutaneous CYP2E1 by DexamethasoneBiochemical and Biophysical Research Communications, 1997
- Monoamine oxidase inhibitors and the cheese effectNeurochemical Research, 1993
- Southern flounder hepatic and intestinal metabolism and DNA binding of benzo[a]pyrene (BaP) metabolites following dietary administration of low doses of BaP, BaP-7,8-dihydrodiol or a BaP metabolite mixtureChemico-Biological Interactions, 1991
- Activation and detoxification of bromobenzene in extrahepatic tissuesLife Sciences, 1984
- Immunohistochemical localization of alcohol dehydrogenase in human kidney, endocrine organs and brainPharmacology Biochemistry and Behavior, 1983
- Influence of food and diet on gastrointestinal drug absorption: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1977